Sucampo Pharmaceuticals, Inc.
Corporation · Wilmington, United States · LEI 549300YPLK5FSJFMAH24
LEI lapsed
Summary
Sucampo Pharmaceuticals, Inc. is registered in the United States. Its legal form is Corporation. No parent is reported to GLEIF. It has 1 direct subsidiary in GLEIF data; 1 of them has a lapsed LEI. The LEI was first issued on 26 Aug 2015 and the record was last updated on 4 Aug 2023. It has lapsed: renewal was due by 24 Jun 2017. GLEIF's ISIN mapping lists 2 ISINs for this LEI. AssetCensus found 1 data-quality note for this entity (see below).
Written from GLEIF data using fixed, reviewed sentence templates.
Data-quality notes (AssetCensus analysis)
- The LEI has lapsed: it was due for renewal by 24 Jun 2017 and was not renewed, so GLEIF's data for this entity has not been re-verified since. A lapsed LEI does not mean the company has ceased to exist.
Company details
| Legal form | Corporation |
|---|---|
| Register | · Register website |
| Registration number | 4630506 |
| Registration authority | Division of Corporations, Department of State |
| Jurisdiction | United States (US-DE) |
| Registered address | C/O Corporation Service Company, 2711 Centerville Road, 19808 Wilmington, United States |
| Headquarters address | 805 King Farm Boulevard, 20850 Rockville, United States |
| Category | company or other legal entity |
| Status | active |
| LEI | 549300YPLK5FSJFMAH24 |
| LEI status | lapsed |
| LEI first issued | 26 Aug 2015 |
| LEI record last updated | 4 Aug 2023 |
| Next LEI renewal | 24 Jun 2017 |
| Corroboration of the LEI record | fully corroborated |
Group membership
Sucampo Pharmaceuticals, Inc. this entity
Direct subsidiaries (1)
- SUCAMPO PHARMA, LLC Japan lapsed · CHIYODA KU
ISINs mapped to this LEI (2)
US8649091068 · US8649092058
2 in the GLEIF–ANNA mapping file. The file covers ISINs issued since the mapping started, not all securities.